Mostrando 4 resultados de: 4
Filtros aplicados
Área temáticas
Medicina y salud(3)
Problemas sociales y servicios a grupos(2)
Derecho(1)
Medicina forense; incidencia de enfermedades(1)
Salud y seguridad personal(1)
Año de Publicación
2022(4)
Origen
scopus(4)
CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study
ArticleAbstract: Background: More doses of CoronaVac have been administered worldwide than any other COVID-19 vaccinePalabras claves:covid-19, Inactivated vaccine, pregnant women, SARS-COV-2, Vaccine effectivenessAutores:Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Pinto Júnior E.P., Rodrigues L.C., Werneck G.L., Wong K.L.M.Fuentes:scopusDuration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
ArticleAbstract: To date, no information has been published on the effectiveness of inactivated whole-virus COVID-19Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopusVaccination plus previous infection: protection during the omicron wave in Brazil
OtherAbstract:Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Florentino P.T.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopusVaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
ArticleAbstract: There is considerable interest in the waning of effectiveness of coronavirus disease 2019 (COVID-19)Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Flores-Ortiz R.J., Júnior J.B.S., Katikireddi S.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Robertson C., Sheikh A., Werneck G.L.Fuentes:scopus